Matthew A. Spear

Insider Reports History

Location
San Diego, CA
Signature
/s/ Harry J. Leonhardt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew A. Spear:

Company Role Class Num Shares Value Price $ Report Date Ownership
Poseida Therapeutics, Inc. Chief Medical Officer Common Stock 111,485 $596,445 $5.35 01 Mar 2022 Direct
Poseida Therapeutics, Inc. Chief Medical Officer Employee Stock Option (Right to Buy) 72,568 01 Mar 2022 Direct

Insider Reports Filed by Matthew A. Spear

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919122014373-spear-matthew-a-2022-03-01 Poseida Therapeutics, Inc. 01 Mar 2022 2 $0 4 Chief Medical Officer 01 Mar 2022, 18:28
/report/000120919121068629-spear-matthew-a-2021-12-06 Poseida Therapeutics, Inc. 06 Dec 2021 2 +$13,220 4 Chief Medical Officer 08 Dec 2021, 19:38
/report/000120919121055443-spear-matthew-a-2021-09-09 Poseida Therapeutics, Inc. 09 Sep 2021 2 +$13,220 4 Chief Medical Officer 10 Sep 2021, 16:19
/report/000120919121053177-spear-matthew-a-2021-08-20 Poseida Therapeutics, Inc. 20 Aug 2021 3 -$29,854 4 Chief Medical Officer 24 Aug 2021, 17:12
/report/000120919121048793-spear-matthew-a-2021-07-28 Poseida Therapeutics, Inc. 28 Jul 2021 2 +$26,440 4 Chief Medical Officer 30 Jul 2021, 16:29
/report/000120919121042292-spear-matthew-a-2021-06-17 Poseida Therapeutics, Inc. 17 Jun 2021 2 +$6,610 4 Chief Medical Officer 21 Jun 2021, 20:02
/report/000120919121040324-spear-matthew-a-2021-06-11 Poseida Therapeutics, Inc. 11 Jun 2021 3 -$32,459 4 Chief Medical Officer 14 Jun 2021, 18:18